167 related articles for article (PubMed ID: 11113576)
1. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice.
Kawakami S; Wong J; Sato A; Hattori Y; Yamashita F; Hashida M
Biochim Biophys Acta; 2000 Dec; 1524(2-3):258-65. PubMed ID: 11113576
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice.
Yeeprae W; Kawakami S; Higuchi Y; Yamashita F; Hashida M
J Drug Target; 2005; 13(8-9):479-87. PubMed ID: 16332573
[TBL] [Abstract][Full Text] [Related]
3. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
Managit C; Kawakami S; Yamashita F; Hashida M
J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
[TBL] [Abstract][Full Text] [Related]
4. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs.
Kawakami S; Munakata C; Fumoto S; Yamashita F; Hashida M
J Pharm Sci; 2001 Feb; 90(2):105-13. PubMed ID: 11169527
[TBL] [Abstract][Full Text] [Related]
5. Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting.
Hattori Y; Kawakami S; Yamashita F; Hashida M
J Control Release; 2000 Dec; 69(3):369-77. PubMed ID: 11102677
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.
Ishida E; Managit C; Kawakami S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2004 Jun; 21(6):932-9. PubMed ID: 15212156
[TBL] [Abstract][Full Text] [Related]
7. Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition.
Murao A; Nishikawa M; Managit C; Wong J; Kawakami S; Yamashita F; Hashida M
Pharm Res; 2002 Dec; 19(12):1808-14. PubMed ID: 12523658
[TBL] [Abstract][Full Text] [Related]
8. In vivo gene delivery to the liver using novel galactosylated cationic liposomes.
Kawakami S; Fumoto S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2000 Mar; 17(3):306-13. PubMed ID: 10801219
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of prostaglandin E1 to hepatocytes using galactosylated liposomes.
Kawakami S; Munakata C; Fumoto S; Yamashita F; Hashida M
J Drug Target; 2000; 8(3):137-42. PubMed ID: 10938523
[TBL] [Abstract][Full Text] [Related]
10. Targeted and sustained drug delivery using PEGylated galactosylated liposomes.
Managit C; Kawakami S; Nishikawa M; Yamashita F; Hashida M
Int J Pharm; 2003 Nov; 266(1-2):77-84. PubMed ID: 14559396
[TBL] [Abstract][Full Text] [Related]
11. The potential role of fucosylated cationic liposome/NFkappaB decoy complexes in the treatment of cytokine-related liver disease.
Higuchi Y; Kawakami S; Yamashita F; Hashida M
Biomaterials; 2007 Jan; 28(3):532-9. PubMed ID: 16982089
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers.
Opanasopit P; Sakai M; Nishikawa M; Kawakami S; Yamashita F; Hashida M
J Control Release; 2002 Apr; 80(1-3):283-94. PubMed ID: 11943405
[TBL] [Abstract][Full Text] [Related]
13. Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver.
Fumoto S; Nakadori F; Kawakami S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2003 Sep; 20(9):1452-9. PubMed ID: 14567641
[TBL] [Abstract][Full Text] [Related]
14. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M
Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149
[TBL] [Abstract][Full Text] [Related]
15. Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells.
Managit C; Kawakami S; Yamashita F; Hashida M
Int J Pharm; 2005 Sep; 301(1-2):255-61. PubMed ID: 16076536
[TBL] [Abstract][Full Text] [Related]
16. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes.
Kawakami S; Sato A; Nishikawa M; Yamashita F; Hashida M
Gene Ther; 2000 Feb; 7(4):292-9. PubMed ID: 10694809
[TBL] [Abstract][Full Text] [Related]
17. Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages.
Opanasopit P; Higuchi Y; Kawakami S; Yamashita F; Nishikawa M; Hashida M
Biochim Biophys Acta; 2001 Mar; 1511(1):134-45. PubMed ID: 11248212
[TBL] [Abstract][Full Text] [Related]
18. Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages.
Yeeprae W; Kawakami S; Yamashita F; Hashida M
J Control Release; 2006 Aug; 114(2):193-201. PubMed ID: 16876282
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine).
Mahato RI; Takemura S; Akamatsu K; Nishikawa M; Takakura Y; Hashida M
Biochem Pharmacol; 1997 Mar; 53(6):887-95. PubMed ID: 9113108
[TBL] [Abstract][Full Text] [Related]
20. Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting
Nie H; Qiu B; Yang QX; Zhao Y; Liu XM; Zhang YT; Liao FL; Zhang SY
J Liposome Res; 2021 Mar; 31(1):79-89. PubMed ID: 31691619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]